Vitreoretinal Fellowship

The Casey Eye Institute-OHSU vitreoretinal fellowship is a two-year comprehensive, AUPO FCC compliant medical and surgical fellowship. Fellows work with experts in the subspecialty areas of medical retina, genetic eye diseases, uveitis, intraocular tumors and pediatric retina. They are also exposed to the evaluation and management of conditions common to the vitreoretinal specialist's practice. We hope to educate leaders in the field by providing excellent, well-rounded training in vitreoretinal diseases in a nurturing, supportive and respectful environment.


Fellows work with the following faculty:

Steven T. Bailey, M.D.

Christina J. Flaxel, M.D.

Thomas S. Hwang, M.D.

Michael L. Klein, M.D.

Andreas K. Lauer, M.D.

Phoebe Lin, M.D., Ph.D

Mark E. Pennesi, M.D., Ph.D.

Joseph E. Robertson, Jr., M.D. M.B.A.

Alison Skalet, M.D., Ph.D

Robert C. Watzke, M.D.

Richard G. Weleber, M.D.

David J. Wilson, M.D.

There is also close collaboration with the uveitis faculty:

James T. Rosenbaum, M.D.

Eric B. Suhler, M.D., M.P.H.

Fellows are exposed to the full range of today's diagnostic and treatment modalities. They are expected to be proficient in the appropriate use and interpretation of ocular echography, including standardized A-scan, time- and spectral-domain optical coherence tomography, fundus autofluorescence, fluorescein and indocyanine green angiography, multifocal and Ganzfeld electroretinogram and electrooculogram by the end of the fellowship. Fellows are trained in a wide array of vitreoretinal procedures, including all modalities of laser photocoagulation, pneumatic retinopexy, intravitreal injections, photodynamic therapy, scleral buckling, vitrectomy with 20-, 23-, and 25-gauge instrumentation and a variety of surgical viewing systems that include the BIOM, the AVI and the endoscopic viewing system. The surgical simulator as well as a wet-lab with vitrectomy instrumentation are available for practice purposes.

Highly trained surgical support staff and well-maintained, state-of-the-art equipment are available at all sites and attending supervision is available for every case. Eye-only operating rooms and staff, as well as amenities such as ready-made intravitreal antibiotics, ensure prompt and efficient completion of emergency cases. Well-trained technicians are present at all clinics, and most sites have photographers trained in phlebotomy for angiography.

The fellowship consists of rotations that include exposure to subspecialty clinics in uveitis, ophthalmic genetics, pediatric retina, as well as general medical and surgical retina.  A wide range of pathology and a diverse patient population are encountered through the rotations as the fellows are entrusted with increasing clinical and surgical independence and responsibilities.

The fellows are responsible for organizing and presenting at the biweekly posterior segment conferences and participate in quarterly retina journal club activity.  Weekly surgical conferences are held for the fellows to review surgical planning, outcomes, and techniques with the faculty.  Fellows' scholarly activities consist of clinical or basic science research as well as some clinical and didactic teaching for the residents. Exceptional laboratory experiences are available, including access to the National Primate Center, which has vitrectomy and advanced ocular imaging capabilities. Fellows are encouraged to submit their work to a peer-reviewed journal and are encouraged to attend national meetings where they have the opportunity to present their research.

There will be a complement of three fellows, alternating between a class of one and two fellows.  We will be matching two positions for the class entering 2014.

Clinical Studies

 Our retina faculty currently participate in the NIH/NEI as well as investigator initiated clinical trials. These include:

  • Age-Related Eye Disease Study II (AREDS 2)
  • Diabetic Retinopathy Clinical Research network (DRCR) studies
  • Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)
  • A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD
  • The Use of a VEGF Inhibitor (Ranibizumab) in Refractory Macular Edema Dueto Eales' Disease
  • Molecular Genetics of Retinal Degenerations (NEI)
  • Repository for Inherited Eye Diseases (NEI)
  • A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa
  • Adalimumab (Humira) in the Treatment of Refractory Non-Infectious Uveitis
  • RPE65 Gene Therapy Trial for Leber Congenital Amaurosis

The Casey Eye Institute participates in the matching program sponsored by the Association of University Professors of Ophthalmology (AUPO). You may contact them regarding match information at (415) 447-0350 or www.SFMATCH.org.

Application Information

This fellowship program requires the SF Match Central Application

Application Deadline

September 6, 2013

 Interview Dates for 2013:
Friday, October 11
Friday, October 18

Please note we will be using Doodle Poll for scheduling interviews.

Contact Information

Thomas S. Hwang, M.D.
Fellowship Director, Retina and Vitreous Service

Fellowship Coordinator: Susan Bony

For further information call: 503 494-3394